AbbVie Presents Results from Phase 3 CANOVA Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma

AbbVie (NYSE: ABBV) today announced data from its Phase 3 CANOVA study evaluating the safety and efficacy of venetoclax (VENCLEXTA®/ VENCLYXTO®) plus dexamethasone (VenDex) for patients with t(11;14)-positive relapsed or refractory (R/R) multiple myeloma who have received two or more…

Read MoreAbbVie Presents Results from Phase 3 CANOVA Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma

Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin Signaling Inhibitor to Treat Adults with Pulmonary Arterial Hypertension (PAH)

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review a new Biologics License Application (BLA) for sotatercept, Merck’s novel investigational activin…

Read MoreMerck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin Signaling Inhibitor to Treat Adults with Pulmonary Arterial Hypertension (PAH)

United Medical Device Cleaning & Recycling Market Insights, 2022-2023 & 2028 Featuring Key Vendors – Steris, Getinge, ECOLAB, 3M, and Stryker – ResearchAndMarkets.com

The “US Medical Device Cleaning & Recycling Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. In the US, the medical device cleaning & recycling market was valued at $3.52 billion in 2022 and is expected to grow at a CAGR…

Read MoreUnited Medical Device Cleaning & Recycling Market Insights, 2022-2023 & 2028 Featuring Key Vendors – Steris, Getinge, ECOLAB, 3M, and Stryker – ResearchAndMarkets.com

AscellaHealth Earns Number One Spot for Fastest Growing Private Company and Number Two Spot on Philadelphia Business Journal “Soaring 76” Overall List of Fastest-Growing Companies

AscellaHealth has ranked second on the Philadelphia Business Journal’s 2023 “Soaring 76” list of fastest-growing companies in Greater Philadelphia and first for fastest-growing private company, as measured by revenue over a three-year period from 2020 through 2022. This is the Company’s fourth time…

Read MoreAscellaHealth Earns Number One Spot for Fastest Growing Private Company and Number Two Spot on Philadelphia Business Journal “Soaring 76” Overall List of Fastest-Growing Companies

PointClickCare Continues to Support the LTPAC Market and Enable Value-Based Care With its Leading Cloud-Based Solutions

PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, announced its presence at the AHCA/NCAL Convention & Expo: Delivering Solutions 23. The company will join the long-term…

Read MorePointClickCare Continues to Support the LTPAC Market and Enable Value-Based Care With its Leading Cloud-Based Solutions

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on September 29, 2023 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan,…

Read MoreSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)